Analysed BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) News Sources
BioMarin and Profluent partner on AI-designed enzyme therapies
01-10-2026
pharmaceutical-technology.com
BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress
02-10-2026
yahoo.com
What is the current price of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The current price of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is $54.795.
BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) since the previous trading day is $-0.095.
BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) since the previous trading day is -0.1731%.
What is the most recent average sentiment score for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The most recent average sentiment score for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The most recent sentiment for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is .
SEC-8K** Filing Available For BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.